BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7963887)

  • 1. [The evaluation of ovarian tumor associated with pregnancy by the ultrasonographical method and serum CA125 levels].
    Fujishita A; Masuzaki H; Nakajima H; Ishimaru T; Yamabe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Sep; 46(9):875-82. PubMed ID: 7963887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline ovarian tumors complicating pregnancy: a case report.
    Wang PH; Chao HT; Too LL; Yang ML; Chiu LM; Chang SP; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Mar; 62(3):179-83. PubMed ID: 10222607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA 125 measurement and ultrasonography in borderline tumors of the ovary.
    Gotlieb WH; Soriano D; Achiron R; Zalel Y; Davidson B; Kopolovic J; Novikov I; Ben-Baruch G
    Am J Obstet Gynecol; 2000 Sep; 183(3):541-6. PubMed ID: 10992171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of transvaginal color Doppler flow imaging conjugated with multiple serum tumor markers in diagnosis of ovarian tumors].
    Wang Y; Liu LZ; Zhou JH; Pei XQ; Chen XY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1585-8. PubMed ID: 15566685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian masses with papillary projections diagnosed and removed during pregnancy: ultrasound features and histological diagnosis.
    Mascilini F; Savelli L; Scifo MC; Exacoustos C; Timor-Tritsch IE; De Blasis I; Moruzzi MC; Pasciuto T; Scambia G; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):116-123. PubMed ID: 27484484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transvaginal color doppler ultrasonography and CA125 detection in surveillance of ovarian malignant tumors after operation].
    Zeng H; Pei XQ; Zheng DM; Zhao YL; Chen XY
    Ai Zheng; 2006 Oct; 25(10):1296-9. PubMed ID: 17059780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective study of 167 ovarian tumors].
    Chechia A; Kaubâa A; Bahri N; Terras K; Makhlouf T
    Tunis Med; 1999 Nov; 77(11):551-7. PubMed ID: 10730141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.
    Buas MF; Gu H; Djukovic D; Zhu J; Drescher CW; Urban N; Raftery D; Li CI
    Gynecol Oncol; 2016 Jan; 140(1):138-44. PubMed ID: 26521694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cysts and cancer in pregnancy.
    Mukhopadhyay A; Shinde A; Naik R
    Best Pract Res Clin Obstet Gynaecol; 2016 May; 33():58-72. PubMed ID: 26707193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of combining detection of human epididymis protein 4 and CA125 in patients with malignant ovarian carcinoma].
    Wang MJ; Qi J; Wang H; Li XX; Wei BJ; Fu C; Gao J; Han BB
    Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):540-3. PubMed ID: 22093635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virilization in pregnancy due to a borderline mucinous ovarian tumor.
    Pather S; Atkinson K; Wang I; Russell P; Kesby G; Carter J
    J Obstet Gynaecol Res; 2007 Jun; 33(3):384-7. PubMed ID: 17578373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of ovarian tumors by sonography].
    Wu ZY; Zhang GY; Du ZB
    Zhonghua Fu Chan Ke Za Zhi; 1994 Feb; 29(2):100-2, 125. PubMed ID: 8033625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of osteopontin in differential diagnosis of ovarian tumors.
    Moszynski R; Szubert S; Szpurek D; Michalak S; Sajdak S
    J Obstet Gynaecol Res; 2013 Nov; 39(11):1518-25. PubMed ID: 23875677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origin of ovarian cancer may have implications for screening.
    Tuma RS
    J Natl Cancer Inst; 2010 Jan; 102(1):11-3. PubMed ID: 20023201
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of celioscopic surgical treatment of ovarian tumors at the beginning of pregnancy].
    Cristalli B; Cayol A; Izard V; Levardon M
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(5):665-8. PubMed ID: 1835468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian tumors in pregnancy].
    Dudkiewicz J; Kowalski T; Grzonka D; Czarnecki M
    Ginekol Pol; 2002 Apr; 73(4):342-5. PubMed ID: 12152281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective study of the correlation of ultrasonography and CA125 in the management of ovarian cysts: a study of 77 cases].
    Mathlouthi N; Ben Ayed B; Dhouib M; Chaabene K; Trabelsi K; Amouri H; Guermazi M
    Tunis Med; 2011; 89(8-9):686-92. PubMed ID: 21948683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian tumors in pregnancy: diagnosis and management.
    Husseinzadeh N; Sibai B; Siddiqi TA
    Am J Perinatol; 2012 May; 29(5):327-34. PubMed ID: 22131044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.